Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Fund Letter | Dominick D'AngeloO'Keefe Stevens Advisory, Inc | Life Sciences Tools & ServicesLife Sciences Tools & Services | O'Keefe Stevens Advisory, Inc - SHC We have been following Sotera Health for several years. The business is... | BULL | View Pitch → | |
| Sep 1, 2026 | Fund Letter | Christopher R. PaveseBroyhill Asset Management | Life Sciences Tools & ServicesLife Sciences Tools & Services | Long SHC (Sotera Health Company) Sotera Health ($SHC) provides mission-critical sterilization, lab testing, and advisory services essential for medical devices and pharmaceuticals. Broyhill initiated the... | BULL | View Pitch → | |
| Aug 21, 2026 | Fund Letter | Chris McIntyreMcIntyre Partnerships | Life Sciences Tools & ServicesLife Sciences Tools & Services | McIntyre Partnerships - SHC SHC saw positive Q1 results, with the key Sterigenics segment continuing its return to HSD organic growth following the COVID destocking in 2023 and 2024. | NEUTRAL | View Pitch → | |
| Aug 7, 2026 | Fund Letter | Chris McIntyreMcIntyre Partnerships | Life Sciences Tools & ServicesLife Sciences Tools & Services | McIntyre Partnerships – SHC SHC saw positive Q1 results, with the key Sterigenics segment continuing its return to HSD organic growth following the COVID destocking in 2023 and 2024. Further, S... | BULL | View Pitch → | |
| Feb 25, 2026 | Fund Letter | Chris McIntyreMcIntyre Partnerships | Life Sciences Tools & ServicesLife Sciences Tools & Services | McIntyre Partnerships 2025 Q4 (SHC) SHC's stock was volatile in 2025 but ultimately finished strong. Despite the share... | BULL | View Pitch → | |
| Jan 8, 2026 | Fund Letter | Chris McIntyreMcIntyre Partnerships | Life Sciences Tools & ServicesLife Sciences Tools & Services | McIntyre Partnerships 2025 Q2 (SHC) Over the last two years, SHC has been experiencing an atypical downturn in its end markets. I describe it... | BULL | View Pitch → | |
| Dec 4, 2025 | Fund Letter | Soho House & Co $SHCO• NASDAQ | -- | Clark Street Value 2025 Q2 (SHCO) Soho House & Co (SHCO) is an operator of private social clubs, late last year, the company announced it had received a $9/share cash offer from a consortium that includes Executive Chairman Ron Burkle. In late January,... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.